<International Circulation>: Management of obesity-related hypertension is a hot research area and most studies focus on pharmacotherapy and bariatric surgery. Can you tell us about some of the progress in this area and discuss treatment adherence in those patients?
《国际循环》:降压治疗的依从性对于高血压患者的心血管保护作用非常重要。在某些患者,治疗依从性差与多种因素有关,除了应用合适的药物和教育患者正确服药以外,医生还有很多工作要做,您怎么看这个问题?
<International Circulation>: Adherence is of very important for the protection of hypertension patients, some patients’ lower treatment adherence is related to more factors, and more work is needed for doctors; this includes not only right instruction but also the right drugs, is that correct?
Sharma教授:正如我刚才所讲到的,当我们谈到肥胖相关的高血压时,通常是指容量依赖性高血压,已经证实在此种情况下有RAAS激活。因此,对于合并超重/肥胖的高血压患者,利尿剂与RAAS阻断药物(ACEI或ARB)联用可能是最佳治疗方案。
Prof. Sharma:So as I mentioned when you talk about obesity-related hypertension you are often talking about hypertension that is volume-dependent albeit we have shown that there is activation of the renin-angiotensin system and so using drugs that block both the renin-angiotensin system like ACE inhibitors or ARBS in combination with diuretics are probably the best anti-hypertensive combination for patients with overweight and obesity presenting with high blood pressure.